LifeStance Health Group (NASDAQ:LFST) Raised to Buy at UBS Group
LifeStance Health Group (NASDAQ:LFST – Get Free Report) was upgraded by analysts at UBS Group from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, Marketbeat.com reports. The brokerage currently has a $8.50 target price on the stock. UBS Group’s target price suggests a potential upside of 40.73% from the […]
LifeStance Health Group (NASDAQ:LFST – Get Free Report) was upgraded by analysts at UBS Group from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, Marketbeat.com reports. The brokerage currently has a $8.50 target price on the stock. UBS Group’s target price suggests a potential upside of 40.73% from the […]
